Summary of Key Information:

Reporting Period (Quarter/Year): Quarter and Half Year ended September 30, 2026

Nature of Filing / Announcement: Outcome of Board Meeting and Unaudited Financial Results

Audit Opinion:

Limited Review Report by Price Waterhouse & Co Chartered Accountants LLP with unmodified conclusion. The review report states nothing has come to their attention that causes them to believe the Statement has not been prepared in all material respects in accordance with recognition and measurement principles laid down in Indian Accounting Standard 34 and other accounting principles generally accepted in India.

Key Financial Highlights [₹ in Crores]:

Standalone Results:

Quarter Ended September 30, 2026:

  • Revenue from Operations: ₹1,452.49
  • Total Income: ₹1,463.66
  • Net Profit before tax and exceptional items: ₹212.32
  • Net Profit for the period after tax: ₹158.48
  • EPS: ₹140.68 (Basic and Diluted)

Quarter Ended September 30, 2025 (Comparison):

  • Revenue from Operations: ₹1,266.49
  • Total Income: ₹1,278.81
  • Net Profit before tax: ₹250.81
  • Net Profit for the period after tax: ₹191.34
  • EPS: ₹169.85 (Basic and Diluted)

Half Year Ended September 30, 2026:

  • Revenue from Operations: ₹2,875.70
  • Total Income: ₹2,898.51
  • Net Profit before tax and exceptional items: ₹441.35
  • Net Profit for the period after tax: ₹391.55
  • EPS: ₹347.58 (Basic and Diluted)

Year Ended March 31, 2026 (Annual Comparison):

  • Revenue from Operations: ₹5,089.76
  • Total Income: ₹5,138.50
  • Net Profit: ₹522.32
  • EPS: ₹463.66 (Basic and Diluted)

Financial Position:

  • Equity Share Capital: ₹11.27 Crores (unchanged)
  • Other Equity: ₹1,756.88 Crores (as of March 31, 2026)
  • Cash and Cash Equivalents: ₹597.33 Crores (as of September 30, 2026)

Segment-wise Performance [₹ in Crores]:

Revenue by Segment for Q2 FY26:

  • Safety & Industrial: ₹452.39
  • Transportation & Electronics: ₹536.66
  • Health Care: ₹278.09
  • Consumer: ₹170.86
  • Others: ₹14.73

Segment Results (Profit) for Q2 FY26:

  • Safety & Industrial: ₹31.24
  • Transportation & Electronics: ₹76.72
  • Health Care: ₹60.22
  • Consumer: ₹29.44
  • Others: ₹7.80
  • Total: ₹205.42

Corporate Actions:

  • The Board approved commencement of Postal Ballot process to seek shareholder approval for appointment of Mr. Chun Hao Lok as Director
  • No dividend declared in this announcement

Other Significant Information:

Business Development:

  • Extended healthcare distribution relationship with Solventum until March 31, 2031
  • Transition of Purification & Filtration (P&F) portfolio distribution rights to Thermo Fisher in India

Exceptional Items:

  • Sale of land located at Pune, India resulting in net expense of ₹73.13 crores for the half year ended September 30, 2026

Management Commentary:

Mr. Aseem Joshi, Managing Director, commented on 14.7% sales growth in Q2 versus prior year with broad-based growth across business segments. Profit decline attributed to Indian Rupee depreciation and input cost inflation due to Middle East crisis.